VAXIMM's Series A Round

VAXIMM raised a round of funding on January 11, 2011.

VAXIMM is a vaccine company that is primarily focused on developing active immunotherapies (vaccines) for patients suffering from cancer.…

Articles about VAXIMM's Series A Round: